Literature DB >> 21994403

Telomere length and TERT functional polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck.

Zhensheng Liu1, Hongxia Ma, Sheng Wei, Guojun Li, Erich M Sturgis, Qingyi Wei.   

Abstract

BACKGROUND: Recent studies reported associations of the relative telomere length (RTL) and TERT variants with risk of several cancers, which have not been comprehensively investigated in squamous cell carcinoma of the head and neck (SCCHN).
METHODS: We detected RTL in peripheral blood lymphocytes and genotyped six selected functional single-nucleotide polymorphisms (SNP) of the TERT gene in 888 SCCHN cases and 885 cancer-free controls of non-Hispanic whites.
RESULTS: Overall, we did not observe significant associations between RTL and SCCHN risk (adjusted OR = 0.97; 95% CI = 0.80-1.17 for below versus above the median; P(trend) = 0.618) nor between the six TERT SNPs and SCCHN risk. We also found no associations between RTL and TERT SNPs.
CONCLUSIONS: Our results suggest that RTL and TERT functional polymorphisms may not play a major role in the etiology of SCCHN. Large prospective studies are needed to validate our findings. IMPACT: Although our results suggest no association among RTL, TERT functional polymorphisms, and SCCHN risk, this study may contribute to future meta-analysis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21994403      PMCID: PMC3237736          DOI: 10.1158/1055-9965.EPI-11-0890

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  9 in total

1.  No association between TERT-CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk.

Authors:  Karen A Pooley; Jonathan Tyrer; Mitul Shah; Kristy E Driver; Jean Leyland; Judith Brown; Tina Audley; Lesley McGuffog; Bruce A J Ponder; Paul D P Pharoah; Douglas F Easton; Alison M Dunning
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-06-22       Impact factor: 4.254

2.  Telomere length in prospective and retrospective cancer case-control studies.

Authors:  Karen A Pooley; Manjinder S Sandhu; Jonathan Tyrer; Mitul Shah; Kristy E Driver; Robert N Luben; Sheila A Bingham; Bruce A J Ponder; Paul D P Pharoah; Kay-Tee Khaw; Douglas F Easton; Alison M Dunning
Journal:  Cancer Res       Date:  2010-04-15       Impact factor: 12.701

3.  Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls.

Authors:  Maria M Gramatges; Melinda L Telli; Raymond Balise; James M Ford
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

4.  Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck.

Authors:  Hongping Yu; Yu-jing Huang; Zhensheng Liu; Li-E Wang; Guojun Li; Erich M Sturgis; David G Johnson; Qingyi Wei
Journal:  Mol Carcinog       Date:  2011-06-07       Impact factor: 4.784

5.  Multiple genetic variants in telomere pathway genes and breast cancer risk.

Authors:  Jing Shen; Marilie D Gammon; Hui-Chen Wu; Mary Beth Terry; Qiao Wang; Patrick T Bradshaw; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01       Impact factor: 4.254

6.  Telomere dysfunction: a potential cancer predisposition factor.

Authors:  Xifeng Wu; Christopher I Amos; Yong Zhu; Hua Zhao; Barton H Grossman; Jerry W Shay; Sherry Luo; Waun Ki Hong; Margaret R Spitz
Journal:  J Natl Cancer Inst       Date:  2003-08-20       Impact factor: 13.506

7.  Sequence variants at the TERT-CLPTM1L locus associate with many cancer types.

Authors:  Thorunn Rafnar; Patrick Sulem; Simon N Stacey; Frank Geller; Julius Gudmundsson; Asgeir Sigurdsson; Margret Jakobsdottir; Hafdis Helgadottir; Steinunn Thorlacius; Katja K H Aben; Thorarinn Blöndal; Thorgeir E Thorgeirsson; Gudmar Thorleifsson; Kristleifur Kristjansson; Kristin Thorisdottir; Rafn Ragnarsson; Bardur Sigurgeirsson; Halla Skuladottir; Tomas Gudbjartsson; Helgi J Isaksson; Gudmundur V Einarsson; Kristrun R Benediktsdottir; Bjarni A Agnarsson; Karl Olafsson; Anna Salvarsdottir; Hjordis Bjarnason; Margret Asgeirsdottir; Kari T Kristinsson; Sigurborg Matthiasdottir; Steinunn G Sveinsdottir; Silvia Polidoro; Veronica Höiom; Rafael Botella-Estrada; Kari Hemminki; Peter Rudnai; D Timothy Bishop; Marcello Campagna; Eliane Kellen; Maurice P Zeegers; Petra de Verdier; Ana Ferrer; Dolores Isla; Maria Jesus Vidal; Raquel Andres; Berta Saez; Pablo Juberias; Javier Banzo; Sebastian Navarrete; Alejandro Tres; Donghui Kan; Annika Lindblom; Eugene Gurzau; Kvetoslava Koppova; Femmie de Vegt; Jack A Schalken; Henricus F M van der Heijden; Hans J Smit; René A Termeer; Egbert Oosterwijk; Onno van Hooij; Eduardo Nagore; Stefano Porru; Gunnar Steineck; Johan Hansson; Frank Buntinx; William J Catalona; Giuseppe Matullo; Paolo Vineis; Anne E Kiltie; José I Mayordomo; Rajiv Kumar; Lambertus A Kiemeney; Michael L Frigge; Thorvaldur Jonsson; Hafsteinn Saemundsson; Rosa B Barkardottir; Eirikur Jonsson; Steinn Jonsson; Jon H Olafsson; Jeffrey R Gulcher; Gisli Masson; Daniel F Gudbjartsson; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2009-01-18       Impact factor: 38.330

Review 8.  Shelterin: the protein complex that shapes and safeguards human telomeres.

Authors:  Titia de Lange
Journal:  Genes Dev       Date:  2005-09-15       Impact factor: 12.890

9.  Shortened telomere length is associated with increased risk of cancer: a meta-analysis.

Authors:  Hongxia Ma; Ziyuan Zhou; Sheng Wei; Zhensheng Liu; Karen A Pooley; Alison M Dunning; Ulrika Svenson; Göran Roos; H Dean Hosgood; Min Shen; Qingyi Wei
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

  9 in total
  13 in total

Review 1.  Human TERT promoter polymorphism rs2853669 is associated with cancers: an updated meta-analysis.

Authors:  Md Abdul Aziz; Sarah Jafrin; Mohammad Safiqul Islam
Journal:  Hum Cell       Date:  2021-03-20       Impact factor: 4.174

2.  Association of Leukocyte Telomere Length and Genes Involved in its Regulation With Oral Carcinoma.

Authors:  Zaneta Jumatovaite; Albertas Kriauciunas; Alvita Vilkeviciute; Greta Gedvilaite; Vykintas Liutkevicius; Virgilijus Uloza; Alina Smalinskiene; Rasa Liutkeviciene
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

3.  Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers.

Authors:  Linda Kachuri; Olli Saarela; Stig Egil Bojesen; George Davey Smith; Geoffrey Liu; Maria Teresa Landi; Neil E Caporaso; David C Christiani; Mattias Johansson; Salvatore Panico; Kim Overvad; Antonia Trichopoulou; Paolo Vineis; Ghislaine Scelo; David Zaridze; Xifeng Wu; Demetrius Albanes; Brenda Diergaarde; Pagona Lagiou; Gary J Macfarlane; Melinda C Aldrich; Adonina Tardón; Gad Rennert; Andrew F Olshan; Mark C Weissler; Chu Chen; Gary E Goodman; Jennifer A Doherty; Andrew R Ness; Heike Bickeböller; H-Erich Wichmann; Angela Risch; John K Field; M Dawn Teare; Lambertus A Kiemeney; Erik H F M van der Heijden; June C Carroll; Aage Haugen; Shanbeh Zienolddiny; Vidar Skaug; Victor Wünsch-Filho; Eloiza H Tajara; Raquel Ayoub Moysés; Fabio Daumas Nunes; Stephen Lam; Jose Eluf-Neto; Martin Lacko; Wilbert H M Peters; Loïc Le Marchand; Eric J Duell; Angeline S Andrew; Silvia Franceschi; Matthew B Schabath; Jonas Manjer; Susanne Arnold; Philip Lazarus; Anush Mukeriya; Beata Swiatkowska; Vladimir Janout; Ivana Holcatova; Jelena Stojsic; Dana Mates; Jolanta Lissowska; Stefania Boccia; Corina Lesseur; Xuchen Zong; James D McKay; Paul Brennan; Christopher I Amos; Rayjean J Hung
Journal:  Int J Epidemiol       Date:  2019-06-01       Impact factor: 7.196

4.  Association of Relative Leucocyte Telomere Length and Gene Single Nucleotide Polymorphisms (TERT, TRF1, TNKS2) in Laryngeal Squamous Cell Carcinoma.

Authors:  Paulius Vaiciulis; Rasa Liutkeviciene; Vykintas Liutkevicius; Alvita Vilkeviciute; Greta Gedvilaite; Virgilijus Uloza
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

5.  Telomere length in peripheral blood lymphocytes contributes to the development of HPV-associated oropharyngeal carcinoma.

Authors:  Yang Zhang; Erich M Sturgis; Kristina R Dahlstrom; Juyi Wen; Hongliang Liu; Qingyi Wei; Guojun Li; Zhensheng Liu
Journal:  Cancer Res       Date:  2013-08-08       Impact factor: 12.701

6.  Lymphocyte telomere length predicts clinical outcomes of HPV-positive oropharyngeal cancer patients after definitive radiotherapy.

Authors:  Xiaoning Luo; Erich M Sturgis; Zheng Yang; Yan Sun; Peng Wei; Zhensheng Liu; Qingyi Wei; Guojun Li
Journal:  Carcinogenesis       Date:  2019-07-06       Impact factor: 4.944

7.  Association between a rare novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of head and neck and lung cancer susceptibility in non-Hispanic Whites.

Authors:  Xiaoxiang Guan; Li-E Wang; Zhensheng Liu; Erich M Sturgis; Qingyi Wei
Journal:  J Cell Mol Med       Date:  2013-06-07       Impact factor: 5.310

8.  Telomere reverse transcriptase (TERT) rs2735940 increases cancer risk.

Authors:  Hui Yang; Jing Li; Ruihua Tang; Yaxiong Liu; Yan Shao; Qingsheng Huang; Junling Shi
Journal:  Med Sci Monit       Date:  2015-02-26

9.  3q26 amplification is an effective negative triage test for LSIL: a historical prospective study.

Authors:  Erica R Heitmann; Kamani M Lankachandra; Jeff Wall; George D Harris; Hollie J McKinney; G Reza Jalali; Yogita Verma; Eric Kershnar; Michael W Kilpatrick; Petros Tsipouras; Diane M Harper
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

Review 10.  Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.

Authors:  Paolo Boscolo-Rizzo; Maria Cristina Da Mosto; Enrica Rampazzo; Silvia Giunco; Annarosa Del Mistro; Anna Menegaldo; Lorena Baboci; Monica Mantovani; Giancarlo Tirelli; Anita De Rossi
Journal:  Cancer Metastasis Rev       Date:  2016-09       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.